Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTt Electronics Regulatory News (TTG)

Share Price Information for Tt Electronics (TTG)

Share Price is delayed by 15 minutes
Get Live Data
115.60    0.00 (0.00%)
Bid:
115.60
Ask:
116.00
Spread: 0.40 (0.346%)
Market Cap: £206.21m
TTG Live PriceLast checked at - London Stock Exchange

Intraday Tt Electronics Share Chart

Director Declaration

12 Jun 2019 09:40

RNS Number : 9488B
TT Electronics PLC
12 June 2019
 

 

 

12 June 2019

 

TT Electronics plc

 

Board Change

 

TT Electronics plc, a global provider of engineered electronics for performance critical applications, today announces that Anne Thorburn will join the Board as a Non-executive Director and member of the Audit and Nominations Committees with effect from 1 July 2019.

 

Anne is a Non-executive Director and Chairman of the Audit Committee at Diploma and a Non-executive Director of BTG. Anne was Chief Financial Officer of Exova from 2009 to 2015 and previously Group Financial Director of British Polythene Industries. Anne is a member of the Institute of Chartered Accountants in Scotland.

 

Neil Carson, Chairman, said "I am delighted to welcome Anne to the Board of TT Electronics. She has many years of experience at Board level in listed international businesses, including those operating in life sciences and medical markets, where TT has a growing presence. Anne has particular expertise in financial management, risk, audit and M&A and I am sure she will make a valuable contribution to the ongoing transformation of TT."

 

The Company confirms that there is no further information to be disclosed under the requirements of Listing Rule 9.6.13R in relation to this appointment.

 

 

For further information please contact:

 

 

 

MHP Communications

Tel: +44 (0)20 3128 8156

Tim Rowntree / Guy Featherstone

 

 

 

   

About TT Electronics

TT Electronics is a global provider of engineered electronics for performance critical applications.

The company operates in industries where there are structural growth drivers, working with market-leading customers in industrial, medical, aerospace and defence, and transportation sectors. Products designed and manufactured include sensors, power management devices and connectivity solutions. TT has design and manufacturing facilities in the UK, US, Sweden and Asia.

The company has three divisions. The Sensors and Specialist Components division works with customers to develop standard and customised solutions including sensors and power management devices. Our solutions improve the precision, speed and reliability of critical aspects of our customers' applications. The Power and Connectivity division designs and manufactures power application products and connectivity devices which enable the capture and wireless transfer of data. We collaborate with our customers to develop innovative solutions to optimise their electronic systems. The Global Manufacturing Solutions division provides manufacturing services and engineering solutions for our product divisions and to customers that often require a lower volume and higher mix of different products. We manufacture complex integrated product assemblies for our customers and provide engineering services including designing testing solutions and value-engineering.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
RDNGGURWQUPBURP
Date   Source Headline
19th Jan 20217:00 amRNSTrading Update
7th Jan 20214:06 pmRNSHolding(s) in Company
4th Jan 202110:46 amRNSTotal Voting Rights
10th Dec 20205:50 pmRNSHolding(s) in Company
1st Dec 20208:52 amRNSTotal Voting Rights
27th Nov 20201:13 pmRNSHolding(s) in Company
17th Nov 20204:59 pmRNSHolding(s) in Company
16th Nov 20203:10 pmRNSHolding(s) in Company
12th Nov 20207:00 amRNSTrading Update
11th Nov 20205:04 pmRNSHolding(s) in Company
2nd Nov 202011:10 amRNSTotal Voting Rights
2nd Nov 202010:23 amRNSBlock listing Six Monthly Return
23rd Oct 202010:42 amRNSHolding(s) in Company
21st Oct 202010:02 amRNSBlock Listing Application
1st Oct 202010:31 amRNSTotal Voting Rights
30th Sep 202010:02 amRNSDirectorate Change
29th Sep 202011:24 amRNSHolding(s) in Company
29th Sep 202011:13 amRNSHolding(s) in Company
23rd Sep 20201:20 pmRNSDirector/PDMR Shareholding
22nd Sep 20203:11 pmRNSDirector/PDMR Shareholding
21st Sep 20204:16 pmRNSDirector/PDMR Shareholding
18th Sep 20207:00 amRNSResults of Placing
17th Sep 20205:00 pmRNSProposed placing of new ordinary shares
17th Sep 20205:00 pmRNSAcquisition
10th Sep 20207:00 amRNSGround-breaking COVID-19 screening device launched
1st Sep 202011:00 amRNSTotal Voting Rights
1st Sep 20207:00 amRNSCollaboration on COVID-19 screening device
6th Aug 20207:00 amRNSInterim Results
3rd Aug 202010:40 amRNSTotal Voting Rights
1st Jul 20209:51 amRNSTotal Voting Rights
9th Jun 20204:20 pmRNSDirector Declaration
8th Jun 20207:00 amRNSTrading Statement
1st Jun 202010:33 amRNSTotal Voting Rights
11th May 202010:46 amRNSBlock Listing Application and Block Listing Update
6th May 20201:31 pmRNSDoc re. Disclosure of Rights Attached to Shares
6th May 20201:07 pmRNSResults of AGM and Directorate Change
6th May 20207:00 amRNSAGM Statement
1st May 20209:41 amRNSTotal Voting Rights
1st May 20209:38 amRNSBlock listing Interim Review
22nd Apr 202012:34 pmRNSDirector/PDMR Shareholding
14th Apr 20202:23 pmRNSDirector/PDMR Shareholding
9th Apr 20204:21 pmRNSAGM Update
3rd Apr 20207:00 amRNSCovid-19 Update
3rd Apr 20207:00 amRNSDirectorate Change
27th Mar 20203:59 pmRNSAnnual Financial Report and notice of AGM
17th Mar 202010:31 amRNSDirector/PDMR Shareholding
13th Mar 20201:00 pmRNSLong Term Incentive Plan 2014
4th Mar 20207:00 amRNSFinal Results
2nd Mar 202011:41 amRNSTotal Voting Rights
31st Jan 20205:05 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.